Brief: Galapagos Says FY Outlook Reaffirmed, Total Net Revenues For HY 140.3 Mln Euros
01/08/2024 21:04
Aug 1 (Reuters) - Galapagos NV GLPG.AS :
* GALAPAGOS NV: 2024 OUTLOOK REAFFIRMED:
* GALAPAGOS NV: TOTAL NET REVENUES FOR SIX MONTHS ENDED 30
JUNE
2024 AMOUNTED TO EUR 140.3 MILLION
* GALAPAGOS NV - HY OPERATING LOSS 71.3 MILLION EUROS VERSUS
27.7
MILLION EUROS
Source text for Eikon: ID:nGNE52nWfs
Further company coverage: GLPG.AS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Lakefront Biotherapeutics NV
See all newsBrief: Lakefront Announces Sale Of Preclinical Car-T Programs To Armed Cell Therapeutics
RBC upgrades Lakefront Biotherapeutics to 'outperform' on gamgertamig prospect
Brief: U.S. FDA Grants Orphan Drug Designation To Gamgertamig For The Treatment Of Pemphigus
Brief: Lakefront Biotherapeutics H1 Net Profit From Continuing Operations €15.8 Mln
Brief: Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline